Page last updated: 2024-11-02

oxonic acid and Hematologic Diseases

oxonic acid has been researched along with Hematologic Diseases in 9 studies

Oxonic Acid: Antagonist of urate oxidase.

Hematologic Diseases: Disorders of the blood and blood forming tissues.

Research Excerpts

ExcerptRelevanceReference
"Here, we reported an interim analysis of feasibility and safety in the first 10 cases of 30 cases in a phase II trial of intravenous and intraperitoneal paclitaxel combined with S-1 for gemcitabine-refractory pancreatic cancer with malignant ascites."9.19Intravenous and intraperitoneal paclitaxel with S-1 for refractory pancreatic cancer with malignant ascites: an interim analysis. ( Hamada, T; Hirano, K; Ijichi, H; Isayama, H; Ishigami, H; Kawakubo, K; Kitayama, J; Kogure, H; Koike, K; Miyabayashi, K; Mizuno, S; Mohri, D; Nakai, Y; Sasahira, N; Sasaki, T; Tada, M; Takahara, N; Tateishi, K; Uchino, R; Watanabe, T; Yamaguchi, H; Yamamoto, N; Yamashita, H, 2014)
"Here, we reported an interim analysis of feasibility and safety in the first 10 cases of 30 cases in a phase II trial of intravenous and intraperitoneal paclitaxel combined with S-1 for gemcitabine-refractory pancreatic cancer with malignant ascites."5.19Intravenous and intraperitoneal paclitaxel with S-1 for refractory pancreatic cancer with malignant ascites: an interim analysis. ( Hamada, T; Hirano, K; Ijichi, H; Isayama, H; Ishigami, H; Kawakubo, K; Kitayama, J; Kogure, H; Koike, K; Miyabayashi, K; Mizuno, S; Mohri, D; Nakai, Y; Sasahira, N; Sasaki, T; Tada, M; Takahara, N; Tateishi, K; Uchino, R; Watanabe, T; Yamaguchi, H; Yamamoto, N; Yamashita, H, 2014)
" We aimed to assess the clinical efficacy and safety of S-1 combined with paclitaxel (PTX) for AGC by performing a systematic review and meta-analysis of the published studies."2.61S-1 combined with paclitaxel may benefit advanced gastric cancer: Evidence from a systematic review and meta-analysis. ( Bian, NN; Min, GT; Wang, YH, 2019)
" Severe adverse events were observed in 22 patients (91."1.42Feasibility and toxicity of adjuvant chemotherapy using S-1 granules for local advanced squamous cell carcinoma of the head and neck. ( Honda, K; Ishikawa, K; Sato, T; Suzuki, S; Yamazaki, K, 2015)
" Five patients showed grade 3 and 4 adverse reactions, all hematological."1.35Safety and efficacy of S-1 chemotherapy in recurrent/metastatic head and neck cancer. ( Ishikawa, K; Suzuki, S, 2009)

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (11.11)29.6817
2010's8 (88.89)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bian, NN1
Wang, YH1
Min, GT1
Takahara, N1
Isayama, H1
Nakai, Y1
Sasaki, T1
Ishigami, H1
Yamashita, H1
Yamaguchi, H1
Hamada, T1
Uchino, R1
Mizuno, S1
Miyabayashi, K1
Mohri, D1
Kawakubo, K1
Kogure, H1
Yamamoto, N1
Sasahira, N1
Hirano, K1
Ijichi, H1
Tateishi, K1
Tada, M1
Kitayama, J1
Watanabe, T1
Koike, K1
Suzuki, S3
Honda, K1
Sato, T1
Yamazaki, K1
Ishikawa, K2
Soh, J1
Okumura, N1
Nakata, M1
Nakamura, H1
Fukuda, M1
Kataoka, M1
Kajiwara, S1
Sano, Y1
Aoe, M1
Kataoka, K1
Hotta, K1
Matsuo, K1
Toyooka, S1
Date, H1
Kobayashi, S1
Ueno, M1
Hara, H1
Irie, K1
Goda, Y1
Moriya, S1
Tezuka, S1
Tanaka, M1
Okusaka, T1
Ohkawa, S1
Morimoto, M1
Choi, IS1
Lee, KW1
Kim, KH1
Kim, YJ1
Kim, JH1
Lee, JS1
Sunaga, T1
Harada, N1
Hayashi, T1
Suzuki, M1
Shiroyama, T1
Komuta, K1
Imamura, F1
Hirashima, T1
Kijima, T1
Tachibana, I1
Kawase, I1

Reviews

1 review available for oxonic acid and Hematologic Diseases

ArticleYear
S-1 combined with paclitaxel may benefit advanced gastric cancer: Evidence from a systematic review and meta-analysis.
    International journal of surgery (London, England), 2019, Volume: 62

    Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Hematologic Diseases; Humans; Oxo

2019

Trials

5 trials available for oxonic acid and Hematologic Diseases

ArticleYear
Intravenous and intraperitoneal paclitaxel with S-1 for refractory pancreatic cancer with malignant ascites: an interim analysis.
    Journal of gastrointestinal cancer, 2014, Volume: 45, Issue:3

    Topics: Adenocarcinoma; Aged; Alopecia; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherap

2014
Randomized feasibility study of S-1 for adjuvant chemotherapy in completely resected Stage IA non-small-cell lung cancer: results of the Setouchi Lung Cancer Group Study 0701.
    Japanese journal of clinical oncology, 2016, Volume: 46, Issue:8

    Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols

2016
Unexpected Side Effects of a High S-1 Dose: Subanalysis of a Phase III Trial Comparing Gemcitabine, S-1 and Combinatorial Treatments for Advanced Pancreatic Cancer.
    Oncology, 2016, Volume: 91, Issue:3

    Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Adenosquamous; Deox

2016
Three-weekly S-1 plus cisplatin chemotherapy as first-line treatment for advanced gastric cancer.
    Medical oncology (Northwood, London, England), 2010, Volume: 27, Issue:3

    Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Disease-Free

2010
Phase II study of S-1 monotherapy in platinum-refractory, advanced non-small cell lung cancer.
    Lung cancer (Amsterdam, Netherlands), 2011, Volume: 74, Issue:1

    Topics: Administration, Oral; Aged; Carcinoma, Non-Small-Cell Lung; Disease Progression; Disease-Free Surviv

2011

Other Studies

3 other studies available for oxonic acid and Hematologic Diseases

ArticleYear
Feasibility and toxicity of adjuvant chemotherapy using S-1 granules for local advanced squamous cell carcinoma of the head and neck.
    Journal of chemotherapy (Florence, Italy), 2015, Volume: 27, Issue:5

    Topics: Administration, Oral; Adult; Aged; Antimetabolites, Antineoplastic; Carcinoma, Squamous Cell; Chemot

2015
Safety and efficacy of S-1 chemotherapy in recurrent/metastatic head and neck cancer.
    Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2009, Volume: 15, Issue:5

    Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Carcinoma, Adenosquamous; Carcinoma, Sq

2009
[Risk associated with severe hematological toxicity in patients with advanced or recurrent colonic cancer receiving combination chemotherapy of S-1 and irinotecan hydrochloride].
    Gan to kagaku ryoho. Cancer & chemotherapy, 2010, Volume: 37, Issue:11

    Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Ch

2010